: In eukaryotes with a double-stranded linear DNA genome, the loss of terminal DNA during replication is inevitable due to an end-replication problem; here, telomeres serve as a buffer against DNA loss. Thus, the activation of the telomere maintenance mechanism (TMM) is a prerequisite for malignant transformation. : We compared neurofibroma (NF, benign) and malignant peripheral nerve sheath tumors (MPNSTs) occurring in the same patient with type 1 neurofibromatosis, where each NF-MPNST pair shared the same genetic background and differentiation lineage; this minimizes the genetic bias and contrasts only those changes that are related to malignant transformation. A total of 20 NF-MPNST pairs from 20 NF1 patients were analyzed. Whole-transcriptome sequencing (WTS) was conducted to profile the transcriptional relationship, and whole-genome sequencing (WGS) was performed to measure the telomere length. : We identified 22 differentially expressed genes (DEGs) during the malignant transformation of MPNSTs. Among them, activated , which sequentially activated , the recombinase of RAD52-dependent alternative lengthening of telomeres (ALT). elongated MPNSTs-telomeres ( = 0.017). Otherwise, neither nor affected telomere length ( = 0.647 and = 0.354, respectively). increased MPNSTs-telomeres length, independently of and in multiple analyses ( = 0.021). The group with increased telomere length during the malignant transformation showed inferior overall survival (OS) (HR = 3.809, = 0.038) to the group without increased telomere length. Accordingly, the group with increased showed inferior OS (HR = 4.896, = 0.046) and metastasis-free survival (MFS) (HR = 9.129, = 0.007) in comparison to the group without increased ; the group with increased showed inferior MFS (HR = 8.669, = 0.011) in comparison to the group without increased . : We suggest that the - transcriptional cascade activates RAD52-dependent ALT to increase telomere length during the malignant transformation of MPNSTs, resulting in a poor prognosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11853032 | PMC |
http://dx.doi.org/10.3390/biomedicines13020281 | DOI Listing |
Oncotarget
March 2025
Worldwide Innovative Network (WIN) Association - WIN Consortium, Chevilly-Larue, France.
The human genome project ushered in a genomic medicine era that was largely unimaginable three decades ago. Discoveries of druggable cancer drivers enabled biomarker-driven gene- and immune-targeted therapy and transformed cancer treatment. Minimizing treatment not expected to benefit, and toxicity-including financial and time-are important goals of modern oncology.
View Article and Find Full Text PDFInt J Gynecol Pathol
March 2025
Emory University Hospital, Atlanta, GA.
Cellular angiofibromas (CAFs) are benign mesenchymal neoplasms of the vulva and lower genitourinary tract. Although most cases are benign with excellent prognosis, data on CAFs with cytologic atypia (aCAF) and sarcomatous transformation (tCAF) is limited. We identified 13 vulvar CAFs comprising 4 aCAFs and 9 tCAFs.
View Article and Find Full Text PDFCells
March 2025
SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP) Pan African Research Institute (PACRI), University of Pretoria, Hartfield, Pretoria 0028, South Africa.
The peremptory need to circumvent challenges associated with poorly differentiated epithelial endometrial cancers (PDEECs), also known as Type II endometrial cancers (ECs), has prompted therapeutic interrogation of the prototypically intractable and most prevalent gynecological malignancy. PDEECs account for most endometrial cancer-related mortalities due to their aggressive nature, late-stage detection, and poor response to standard therapies. PDEECs are characterized by heterogeneous histopathological features and distinct molecular profiles, and they pose significant clinical challenges due to their propensity for rapid progression.
View Article and Find Full Text PDFCurr Opin Oncol
February 2025
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Baltimore, Maryland, USA.
Purpose Of Review: Normal and malignant prostate engage in high rates of de novo polyamine synthesis. This review considers how polyamine metabolism regulates prostate cancer initiation and progression.
Recent Findings: The androgen receptor (AR) establishes a metabolic program to drive robust polyamine synthesis in the normal prostate.
Indian J Otolaryngol Head Neck Surg
January 2025
Department of Otorhinolaryngology and Head and Neck surgery, J.J.M Medical College, Davangere, Karnataka India.
Benign swellings of the thyroid gland are a common occurrence, frequently seen in surgical practice. Regardless of their appearance, however, it is a must to ultrasonologically analyse them in order to confirm their morphology and pick up any warning signs which might point towards a malignant transformation. In this particular study, we analyzed the morphological features (ultrasonological) associated with benign goitrogenous lesions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!